To create a healthier future for patients with life-threatening diseases, Engitix Therapeutics is using its pioneering human extracellular matrix (ECM)-based discovery platform to develop a portfolio of programmes in fibrosis and solid tumors.

Biotechnology

Engitix Therapeutics

Engitix Therapeutics' headquarters in London, United Kingdom

Giuseppe Mazza

Chris Stevenson

Andy Roland-Price

Amélie Fortin

Antonio Di Sabatino

Mario Strazzabosco

Giuseppe Fusai

Emmanuel Tsochatzis

Doug Thorburn

Tu Vinh Luong

Mike Platt

Gianluca Rosetti

Melissa Palmer

Hendrik-Tobias Arkenau

Eduardo Bravo

Massimo Pinzani

Sonia Quaratino

The Science Team at Engitix Therapeutics leverages their expertise in drug discovery, tissue engineering, and translational biology to advance the company's portfolio of programs targeting fibrosis and solid tumors. This team utilizes the company's human extracellular matrix (ECM)-based discovery platform to develop innovative therapeutic solutions, bringing together a multidisciplinary group of scientists and advisors to drive research and development.

Science Team

The Research and Development team at Engitix Therapeutics leverages the company's pioneering human extracellular matrix (ECM)-based discovery platform to create innovative therapeutic programs targeting fibrosis and solid tumors. Comprising experts in biospecimens, biology, biomaterials, fibrosis, medicinal chemistry, and immuno-oncology, the team focuses on advancing the understanding and treatment of life-threatening diseases to ensure a healthier future for patients.

Research and Development

The Finance and Operations team at Engitix Therapeutics manages the company's financial activities, including budgeting, accounting, and financial planning. They also oversee operational logistics to ensure the seamless execution of business processes, supporting the company's mission to develop therapies for fibrosis and solid tumors.

Finance and Operations

The Leadership Team at Engitix Therapeutics guides the strategic direction and vision of the company, leveraging their expertise in therapeutics and scientific innovation. Comprised of the CEO & Co-founder, Chief Scientific Officer, and Vice President of Fibrosis, this team drives the development of ECM-based therapies to address life-threatening diseases, ensuring alignment between research initiatives and market needs while fostering a collaborative culture.

Engitix Therapeutics

Org chart

Board & advisors

Teams

Science Team

Research and Development

Finance and Operations

Leadership Team

Offices

Engitix Therapeutics

Org chart

Board & advisors

Teams

Science Team

Research and Development

Finance and Operations

Leadership Team

Offices

Related companies